Diagnosoft® VIRTUE and Diagnosoft® PULSE Debuts at SCMR 15th Annual Scientific Sessions, Marriott World Center, Orlando FL, Feb. 2-5th 2012

ORLANDO, Fla. and MORRISVILLE, N.C., Feb. 2, 2012 /PRNewswire/ -- SCMR 15th Annual Scientific Sessions -- Diagnosoft®, Inc., a pioneer in the development of cardiovascular clinical analytics and advanced cardiac MRI analysis software for diagnosing, staging, and monitoring cardiovascular disease, today announced the official release of its latest analysis and reporting solutions, Diagnosoft VIRTUE and Diagnosoft PULSE. 

Diagnosoft VIRTUE is the latest update to Diagnosoft's industry leading cardiac MRI analysis platform and includes newly integrated clinical workflow, enterprise IT connectivity, enhanced measurements, and viewing modules to provide the most comprehensive platform for cardiac MRI analysis on the market.  Diagnosoft PULSE, Diagnosoft's new advanced imaging structured reporting software, will provide cardiologists and radiologists with a comprehensive, web based, vendor independent, integrated structured reporting platform for advanced cardiac imaging, including cardiac MRI.

Company representatives will offer live demonstrations of both products at Booth #28 throughout the SCMR event Feb. 2-4 at the Orlando Marriott Convention Center.

"Diagnosoft VIRTUE and PULSE enable customers to utilize a single source for all of their image analysis and reporting needs.  We will be offering our most powerful modules, including HARP, CORE and SENC, into one comprehensive and connected enterprise suite.  Cardiologists and radiologists will be able to analyze cardiac function quickly and efficiently, and then readily create a final diagnostic report that combines, analyzed data, graphs and charts, and relevant images." said Firas BenAchour, president and CEO of Diagnosoft. "Our solutions are unique in the marketplace, and we're very pleased to unveil these new, more powerful products at SCMR."

Diagnosoft VIRTUE, with its specialized and integrated modules, delivers end-to-end, 360-degree perspective and analysis of regional and global heart function. Diagnosoft VIRTUE builds on Diagnosoft's well-established reputation for leadership in cardiac MRI analysis. Two of Diagnosoft's flagship modules — HARP and SENC — have transformed the industry by greatly expanding the scope and significantly enhancing the detail of cardiac MRI analysis.  Diagnosoft VIRTUE leverages Diagnosoft® OMNEA, an enterprise middleware and connectivity platform, allowing VIRTUE to interoperate with all technology and imaging platforms, enterprise hospital systems, and IT infrastructures.

Diagnosoft® PULSE is a vendor-independent and enterprise structured reporting solution for advanced cardiac imaging.  It automatically generates patient-specific structured reports based on the analysis and quantification results obtained by Diagnosoft VIRTUE.  Diagnosoft PULSE is also capable of reading and integrating advanced imaging measurement data from all imaging modalities and vendors.  As a result, Diagnosoft PULSE delivers the enterprise flexibility and connectivity healthcare organizations value, and generates comprehensive reports that incorporate all available cardiac quantification data and results.

For more information about Diagnosoft VIRTUE, Diagnosoft PULSE, or other products or services by Diagnosoft, please visit Booth #28 at the SCMR 15th Annual Scientific Sessions, Marriott World Center, Orlando, FL, Feb. 2-5, 2012, or visit www.diagnosoft.com.

About Diagnosoft

Diagnosoft, Inc., based in RTP, North Carolina, is a privately held company that develops cardiovascular clinical analytics and MRI analysis software that assists in the diagnosis, staging and therapeutic monitoring of cardiovascular disease. Our solutions empower proactive and personalized patient care by providing physicians with real time, actionable clinical signals, concerning any immediate or predictable future clinical events or changes with patient health status.  Diagnosoft's focus is on detecting these events,   which are the leading cause of hospital admissions and re-admissions, deterioration in patient health, and premature mortality. For more information, visit www.diagnosoft.com

SOURCE Diagnosoft, Inc.